• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型GluN2B选择性N-甲基-D-天冬氨酸受体拮抗剂:7-甲氧基-2-甲基-2,3,4,5-四氢-1H-3-苯并氮杂卓-1-醇的相对构型

Novel GluN2B selective NMDA receptor antagonists: relative configuration of 7-meth-oxy-2-methyl-2,3,4,5-tetra-hydro-1H-3-benzazepin-1-ols.

作者信息

Tewes Bastian, Frehland Bastian, Fröhlich Roland, Wünsch Bernhard

机构信息

Institut für Pharmazeutische und Medizinische Chemie der Universität Münster, Corrensstrasse 48, D-48149 Münster, Germany.

Organisch-chemisches Institut der Westfälischen Wilhelms-Universität Münster, Corrensstr. 40, D-48149-Münster, Germany.

出版信息

Acta Crystallogr E Crystallogr Commun. 2016 Apr 15;72(Pt 5):687-91. doi: 10.1107/S2056989016005843. eCollection 2016 May 1.

DOI:10.1107/S2056989016005843
PMID:27308019
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4908524/
Abstract

The title compounds, C22H29NO2 (3) and C22H29NO2 (4) [systematic names: (1S*,2R*)-7-meth-oxy-2-methyl-3-(4-phenyl-but-yl)-2,3,4,5-tetra-hydro-1H-3-benzazepin-1-ol and (1R*,2R*)-7-meth-oxy-2-methyl-3-(4-phenyl-but-yl)-2,3,4,5-tetra-hydro-1H-3-benzazepin-1-ol, are diastereomers with the relative configuration of the adjacent hydroxyl and methyl groups at the seven-membered azepine ring being trans in (3) and cis in (4). In the crystals the orientation of these groups is -anti-periplanar (3) and +syn-clinal (4). In both cases, the crystals studied proved to be of a racemic mixture, with relative configurations (R*,S*)-3 and (R*,R*)-4. In both compounds, the seven-membered azepine ring has a chair-like conformation, and the 4-phenyl-butyl side chain adopts a extended conformation in (R*,S*)-3, but a twisted conformation in (R*,R*)-4. In the crystal of (S*,R*)-3, mol-ecules are linked via C-H⋯O hydrogen bonds, forming slabs parallel to the ac plane. In the crystal of (R*,R*)-4, mol-ecules are linked via O-H⋯N hydrogen bonds, forming chains propagating along the c-axis direction. The chains are linked by C-H⋯O hydrogen bonds, forming slabs parallel to the ac plane.

摘要

标题化合物C22H29NO2(3)和C22H29NO2(4)[系统名称:(1S*,2R*)-7-甲氧基-2-甲基-3-(4-苯基丁基)-2,3,4,5-四氢-1H-3-苯并氮杂卓-1-醇和(1R*,2R*)-7-甲氧基-2-甲基-3-(4-苯基丁基)-2,3,4,5-四氢-1H-3-苯并氮杂卓-1-醇]是非对映异构体,七元氮杂卓环上相邻羟基和甲基的相对构型在(3)中为反式,在(4)中为顺式。在晶体中,这些基团的取向为-反叠式(3)和+顺错式(4)。在这两种情况下,所研究的晶体均为外消旋混合物,相对构型为(R*,S*)-3和(R*,R*)-4。在这两种化合物中,七元氮杂卓环均呈椅式构象,(R*,S*)-3中的4-苯基丁基侧链呈伸展构象,而(R*,R*)-4中的则呈扭曲构象。在(S*,R*)-3的晶体中,分子通过C-H⋯O氢键相连,形成平行于ac平面的片层。在(R*,R*)-4的晶体中,分子通过O-H⋯N氢键相连,形成沿c轴方向延伸的链。这些链通过C-H⋯O氢键相连,形成平行于ac平面的片层。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4908524/1d861e7fd3ec/e-72-00687-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4908524/46885d65a163/e-72-00687-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4908524/09d8b2f2e5bf/e-72-00687-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4908524/3329c6121f50/e-72-00687-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4908524/bab0f430a1d0/e-72-00687-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4908524/1d861e7fd3ec/e-72-00687-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4908524/46885d65a163/e-72-00687-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4908524/09d8b2f2e5bf/e-72-00687-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4908524/3329c6121f50/e-72-00687-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4908524/bab0f430a1d0/e-72-00687-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4908524/1d861e7fd3ec/e-72-00687-fig5.jpg

相似文献

1
Novel GluN2B selective NMDA receptor antagonists: relative configuration of 7-meth-oxy-2-methyl-2,3,4,5-tetra-hydro-1H-3-benzazepin-1-ols.新型GluN2B选择性N-甲基-D-天冬氨酸受体拮抗剂:7-甲氧基-2-甲基-2,3,4,5-四氢-1H-3-苯并氮杂卓-1-醇的相对构型
Acta Crystallogr E Crystallogr Commun. 2016 Apr 15;72(Pt 5):687-91. doi: 10.1107/S2056989016005843. eCollection 2016 May 1.
2
Crystal structure of (1S*,2R*)-7-benz-yloxy-2-methyl-3-tosyl-2,3,4,5-tetra-hydro-1H-3-benz-azepin-1-ol: elucidation of the relative configuration of potent allosteric GluN2B selective NMDA receptor antagonists.(1S*,2R*)-7-苄氧基-2-甲基-3-对甲苯磺酰基-2,3,4,5-四氢-1H-3-苯并氮杂卓-1-醇的晶体结构:强效变构GluN2B选择性NMDA受体拮抗剂相对构型的阐明
Acta Crystallogr E Crystallogr Commun. 2016 Apr 15;72(Pt 5):683-6. doi: 10.1107/S2056989016005855. eCollection 2016 May 1.
3
Crystal structure of (3*,4*)-4-fluoro-3-(4-meth-oxy-phen-yl)-1-oxo-2-phenyl-1,2,3,4-tetra-hydro-iso-quinoline-4-carb-oxy-lic acid.(3*,4*)-4-氟-3-(4-甲氧基-苯基)-1-氧代-2-苯基-1,2,3,4-四氢异喹啉-4-羧酸的晶体结构
Acta Crystallogr E Crystallogr Commun. 2017 May 23;73(Pt 6):867-870. doi: 10.1107/S2056989017007186. eCollection 2017 Jun 1.
4
Comparison of the crystal structures of methyl 4-bromo-2-(meth-oxy-meth-oxy)benzoate and 4-bromo-3-(meth-oxy-meth-oxy)benzoic acid.4-溴-2-(甲氧基甲氧基)苯甲酸甲酯与4-溴-3-(甲氧基甲氧基)苯甲酸的晶体结构比较。
Acta Crystallogr E Crystallogr Commun. 2016 Mar 11;72(Pt 4):477-81. doi: 10.1107/S2056989016003777. eCollection 2016 Apr 1.
5
Three-component reaction between isatoic anhydride, amine and meth-yl-subs-tituted furyl-acryl-alde-hydes: crystal structures of 3-benzyl-2-[()-2-(5-methylfuran-2-yl)vin-yl]-2,3-di-hydro-quinazolin-4(1)-one, 3-benzyl-2-[()-2-(furan-2-yl)-1-methyl-vin-yl]-2,3-di-hydro-quinazolin-4(1)-one and 3-(furan-2-ylmeth-yl)-2-[()-2-(furan-2-yl)-1-methyl-vin-yl]-2,3-di-hydro-quinazolin-4(1)-one.异吲哚啉酮、胺与甲基取代的呋喃基丙烯醛之间的三组分反应:3-苄基-2-[(Z)-2-(5-甲基呋喃-2-基)乙烯基]-2,3-二氢喹唑啉-4(1)-酮、3-苄基-2-[(Z)-2-(呋喃-2-基)-1-甲基乙烯基]-2,3-二氢喹唑啉-4(1)-酮和3-(呋喃-2-基甲基)-2-[(Z)-2-(呋喃-2-基)-1-甲基乙烯基]-2,3-二氢喹唑啉-4(1)-酮的晶体结构
Acta Crystallogr E Crystallogr Commun. 2018 Jul 13;74(Pt 8):1101-1106. doi: 10.1107/S2056989018009982. eCollection 2018 Aug 1.
6
Crystal structure of ethyl 6-methyl-2-oxo-4-(3,4,5-tri-meth-oxy-phen-yl)-1,2,3,4-tetra-hydro-pyrimidine-5-carboxyl-ate.6-甲基-2-氧代-4-(3,4,5-三甲氧基苯基)-1,2,3,4-四氢嘧啶-5-羧酸乙酯的晶体结构
Acta Crystallogr E Crystallogr Commun. 2015 Feb 25;71(Pt 3):o206-7. doi: 10.1107/S2056989015003576. eCollection 2015 Mar 1.
7
Crystal structure of 10-benzyl-9-(3,4-di-meth-oxy-phen-yl)-3,3,6,6-tetra-methyl-3,4,6,7,9,10-hexa-hydro-acridine-1,8(2H,5H)-dione.10-苄基-9-(3,4-二甲氧基苯基)-3,3,6,6-四甲基-3,4,6,7,9,10-六氢吖啶-1,8(2H,5H)-二酮的晶体结构
Acta Crystallogr E Crystallogr Commun. 2015 Aug 26;71(Pt 9):o688-9. doi: 10.1107/S2056989015014966. eCollection 2015 Sep 1.
8
(2R,3S,4R,5R)-5-(4-Amino-5-iodo-7H-pyrrolo-[2,3-d]pyrimidin-7-yl)-4-fluoro-2-(hy-droxy-meth-yl)tetra-hydro-furan-3-ol.(2R,3S,4R,5R)-5-(4-氨基-5-碘-7H-吡咯并[2,3-d]嘧啶-7-基)-4-氟-2-(羟甲基)四氢呋喃-3-醇
Acta Crystallogr Sect E Struct Rep Online. 2014 Jan 8;70(Pt 2):o120. doi: 10.1107/S1600536813034995. eCollection 2014 Feb 1.
9
3-(3-Chloro-prop-yl)-7,8-dimeth-oxy-2,3,4,5-tetra-hydro-1H-3-benzazepin-2-one at 125 K.125K温度下的3-(3-氯丙基)-7,8-二甲氧基-2,3,4,5-四氢-1H-3-苯并氮杂卓-2-酮
Acta Crystallogr Sect E Struct Rep Online. 2008 Apr 4;64(Pt 5):o802. doi: 10.1107/S1600536808008787.
10
Crystal structure of (5R)-5-[(1S)-1,2-di-hydroxy-eth-yl]-4-meth-oxy-3-phenyl-2,5-di-hydro-furan-2-one.(5R)-5-[(1S)-1,2-二羟基乙基]-4-甲氧基-3-苯基-2,5-二氢呋喃-2-酮的晶体结构
Acta Crystallogr Sect E Struct Rep Online. 2014 Sep 30;70(Pt 10):o1141-2. doi: 10.1107/S1600536814021370. eCollection 2014 Oct 1.

本文引用的文献

1
Enantiomerically Pure 2-Methyltetrahydro-3-benzazepin-1-ols Selectively Blocking GluN2B Subunit Containing N-Methyl-D-aspartate Receptors.手性纯的 2-甲基四氢-3-苯氮杂䓬-1-醇选择性阻断含 N-甲基-D-天冬氨酸受体的 GluN2B 亚基。
J Med Chem. 2015 Aug 13;58(15):6293-305. doi: 10.1021/acs.jmedchem.5b00897. Epub 2015 Jul 30.
2
Metabolism studies of ifenprodil, a potent GluN2B receptor antagonist.依酚氯胺(一种有效的 GluN2B 受体拮抗剂)的代谢研究。
J Pharm Biomed Anal. 2014 Jan;88:96-105. doi: 10.1016/j.jpba.2013.08.014. Epub 2013 Aug 21.
3
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease.
NMDA 受体亚单位多样性:对受体特性、突触可塑性和疾病的影响。
Nat Rev Neurosci. 2013 Jun;14(6):383-400. doi: 10.1038/nrn3504.
4
Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors.GluN1/GluN2B NMDA 受体的亚基排列和苯乙醇胺结合。
Nature. 2011 Jun 15;475(7355):249-53. doi: 10.1038/nature10180.
5
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.基于异氟烷的构象限制型 NR2B 选择性 NMDA 受体拮抗剂:四氢-3-苯并氮杂卓-1,7-二醇的合成与生物学评价。
Bioorg Med Chem. 2010 Nov 15;18(22):8005-15. doi: 10.1016/j.bmc.2010.09.026. Epub 2010 Sep 24.
6
Development of a selective competitive receptor binding assay for the determination of the affinity to NR2B containing NMDA receptors.开发一种选择性竞争受体结合测定法,用于测定与含有 NR2B 的 NMDA 受体的亲和力。
J Pharm Biomed Anal. 2010 Nov 2;53(3):603-8. doi: 10.1016/j.jpba.2010.04.014. Epub 2010 Apr 18.
7
Design, Synthesis, and Biological Evaluation of 3-Benzazepin-1-ols as NR2B-Selective NMDA Receptor Antagonists.3-苯并氮杂卓-1-醇类作为 NR2B 选择性 NMDA 受体拮抗剂的设计、合成与生物评价。
ChemMedChem. 2010 May 3;5(5):687-95. doi: 10.1002/cmdc.201000005.
8
Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain.靶向 NMDA 受体亚单位 NR2B 治疗神经性疼痛。
Neurotherapeutics. 2009 Oct;6(4):693-702. doi: 10.1016/j.nurt.2009.07.008.
9
Structure validation in chemical crystallography.化学晶体学中的结构验证
Acta Crystallogr D Biol Crystallogr. 2009 Feb;65(Pt 2):148-55. doi: 10.1107/S090744490804362X. Epub 2009 Jan 20.
10
A short history of SHELX.SHELX简史。
Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22. doi: 10.1107/S0108767307043930. Epub 2007 Dec 21.